Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,945 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab.
Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima AM, Niitsu N, Ennishi D, Tamaru JI, Ishizawa K, Kashimura M, Kagami Y, Sunami K, Yamane H, Nishikori M, Kosugi H, Yujiri T, Hyo R, Katayama N, Kinoshita T, Nakamura S. Miyazaki K, et al. Among authors: yamaguchi m. Ann Oncol. 2011 Jul;22(7):1601-1607. doi: 10.1093/annonc/mdq627. Epub 2011 Jan 3. Ann Oncol. 2011. PMID: 21199885 Free article.
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ennishi D, Takeuchi K, Yokoyama M, Asai H, Mishima Y, Terui Y, Takahashi S, Komatsu H, Ikeda K, Yamaguchi M, Suzuki R, Tanimoto M, Hatake K. Ennishi D, et al. Among authors: yamaguchi m. Ann Oncol. 2008 Nov;19(11):1921-6. doi: 10.1093/annonc/mdn392. Epub 2008 Jun 23. Ann Oncol. 2008. PMID: 18573805 Free article.
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
Suzuki R, Suzumiya J, Yamaguchi M, Nakamura S, Kameoka J, Kojima H, Abe M, Kinoshita T, Yoshino T, Iwatsuki K, Kagami Y, Tsuzuki T, Kurokawa M, Ito K, Kawa K, Oshimi K; NK-cell Tumor Study Group. Suzuki R, et al. Among authors: yamaguchi m. Ann Oncol. 2010 May;21(5):1032-40. doi: 10.1093/annonc/mdp418. Epub 2009 Oct 22. Ann Oncol. 2010. PMID: 19850638 Free article.
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T, Seto M, Nakamura S. Yatabe Y, et al. Among authors: yamaguchi m. Blood. 2000 Apr 1;95(7):2253-61. Blood. 2000. PMID: 10733493 Free article.
Morphological spectrum of cyclin D1-positive mantle cell lymphoma: study of 168 cases.
Yatabe Y, Suzuki R, Matsuno Y, Tobinai K, Ichinohazama R, Tamaru J, Mizoguchi Y, Hashimoto Y, Yamaguchi M, Kojima M, Uike N, Okamoto M, Isoda K, Ichimura K, Morishima Y, Seto M, Suchi T, Nakamura S. Yatabe Y, et al. Among authors: yamaguchi m. Pathol Int. 2001 Oct;51(10):747-61. doi: 10.1046/j.1440-1827.2001.01277.x. Pathol Int. 2001. PMID: 11881727
Root canal irrigation with citric acid solution.
Yamaguchi M, Yoshida K, Suzuki R, Nakamura H. Yamaguchi M, et al. J Endod. 1996 Jan;22(1):27-9. doi: 10.1016/S0099-2399(96)80232-9. J Endod. 1996. PMID: 8618082
[Clinical significance of micromegakaryocytes in de novo AML].
Kobayashi S, Seki K, Katayama N, Akiba C, Yamamoto T, Sakai K, Yamaguchi M, Maruta A, Noguchi T, Ogawa K, et al. Kobayashi S, et al. Among authors: yamaguchi m. Rinsho Ketsueki. 1993 Mar;34(3):313-20. Rinsho Ketsueki. 1993. PMID: 8479083 Japanese.
Ileocolonic lymphomas: a series of 16 cases.
Saito T, Toyoda H, Yamaguchi M, Nakamura T, Nakamura S, Mukai K, Fuke H, Wakita Y, Iwata M, Adachi Y, Shiku H. Saito T, et al. Among authors: yamaguchi m. Endoscopy. 2005 May;37(5):466-9. doi: 10.1055/s-2005-861093. Endoscopy. 2005. PMID: 15844027
5,945 results